Prognostic Indicators Identified for Bladder Cancer With Isolated Lymph Node Metastasis
A new study published in Urologic Oncology: Seminars and Original Investigations sheds light on the natural history and outcomes of urothelial carcinoma of the bladder (UCB) with isolated lymph node metastasis after surgical resection. While patients with UCB and pathologic lymph node involvement have a poor prognosis, some patients have experienced durable survival following surgical resection. To date, data that describe the natural history of UCB in patients with isolated lymph node involvement (cN0pN+) following radical cystectomy with pelvic lymph node dissection are ...
Advertisement
Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

Conference Coverage

Live meeting highlights

Leah LawrenceESMO 2022 | September 16, 2022
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
Read More
Leah LawrenceESMO 2022 | September 16, 2022
CLEAR study results showed that treatment with first-line lenvatinib plus pembrolizumab had clinical benefit at 2 years.
Leah LawrenceESMO 2022 | September 16, 2022
The RACE IT trial finds neoadjuvant radio-immunotherapy followed by radical cystectomy a safe and feasible treatment option.
Patrick DalyESMO 2022 | September 14, 2022
Patients with mCRPC with AR alterations had significantly worse survival outcomes compared with patients with wild-type.

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Expert Interviews

Clinical discussions with experts in the field

Journal

Articles from the GU Oncology Now Journal